Insider Monkey
Jim Cramer on HCA Healthcare: “I Want You to Buy It Only in Big Clumps”
📈
AI Sentiment
Highly Positive
8/10
- Home
- HCA
as of 03-20-2026 3:39pm EST
$491.72
$7.94
-1.59%
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
| Founded: | 1968 | Country: | United States |
| Employees: | N/A | City: | NASHVILLE |
| Market Cap: | 119.1B | IPO Year: | 2009 |
| Target Price: | $528.00 | AVG Volume (30 days): | 912.1K |
| Analyst Decision: | Buy | Number of Analysts: | 21 |
| Dividend Yield: | Dividend Payout Frequency: | monthly | |
| EPS: | 28.33 | EPS Growth: | 28.77 |
| 52 Week Low/High: | $314.43 - $556.52 | Next Earning Date: | 04-24-2026 |
| Revenue: | $75,600,000,000 | Revenue Growth: | 7.08% |
| Revenue Growth (this year): | 5.1% | Revenue Growth (next year): | 4.90% |
| P/E Ratio: | 17.64 | Index: | |
| Free Cash Flow: | 7.7B | FCF Growth: | +36.41% |
AI-Powered HCA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 70.37%
70.37%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of HCA Healthcare Inc. (HCA)
McAlevey Michael R
Sell
EVP & Chief Legal & Admin Off.
HCA Feb 18, 2026
Avg Cost/Share
$533.37
Shares
1,694
Total Value
$903,536.74
Owned After
8,853
SEC Form 4
Wyatt Christopher F.
Sell
SVP & Controller
HCA Feb 11, 2026
Avg Cost/Share
$505.00
Shares
4,000
Total Value
$2,020,000.00
Owned After
44,379
SEC Form 4
Berres Jennifer
Sell
SVP & Chief Human Res. Officer
HCA Feb 11, 2026
Avg Cost/Share
$514.58
Shares
8,020
Total Value
$4,126,950.05
Owned After
16,003
HAZEN SAMUEL N
Sell
CEO
HCA Feb 3, 2026
Avg Cost/Share
$499.99
Shares
42,877
Total Value
$21,483,274.82
Owned After
60,437
Cuffe Michael S.
Sell
EVP and Chief Clinical Officer
HCA Feb 3, 2026
Avg Cost/Share
$498.09
Shares
1,500
Total Value
$747,135.15
Owned After
30,002.902
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| McAlevey Michael R | HCA | EVP & Chief Legal & Admin Off. | Feb 18, 2026 | Sell | $533.37 | 1,694 | $903,536.74 | 8,853 | |
| Wyatt Christopher F. | HCA | SVP & Controller | Feb 11, 2026 | Sell | $505.00 | 4,000 | $2,020,000.00 | 44,379 | |
| Berres Jennifer | HCA | SVP & Chief Human Res. Officer | Feb 11, 2026 | Sell | $514.58 | 8,020 | $4,126,950.05 | 16,003 | |
| HAZEN SAMUEL N | HCA | CEO | Feb 3, 2026 | Sell | $499.99 | 42,877 | $21,483,274.82 | 60,437 | |
| Cuffe Michael S. | HCA | EVP and Chief Clinical Officer | Feb 3, 2026 | Sell | $498.09 | 1,500 | $747,135.15 | 30,002.902 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Jan 27, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLJan 27, 2026 · 100% conf.
AI Prediction SELL
1D
-1.35%
$499.03
Act: -2.89%
5D
-2.21%
$494.67
Act: -1.31%
20D
-1.38%
$498.86
Act: +6.87%
Price: $505.84 Prob +5D: 0% AUC: 1.000
0001193125-26-023323
8-K
false000086073000008607302026-01-272026-01-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 27, 2026
HCA Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter)
Delaware
001-11239
27-3865930
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
One Park Plaza
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: (615) 344-9551
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
HCA
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition. On January 27, 2026, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its results of operations for the fourth quarter and year ended December 31, 2025, the text of which is set forth as Exhibit 99.1. Item 7.01. Regulation FD Disclosure. On January 27, 2026, the Company issued a press release announcing, among other matters, its results of operations for the fourth quarter and year ended December 31, 2025, the text of which is set forth as Exhibit 99.1. Item 8.01. Other Events. On January 27, 2026, the Company announced that its Board of Directors had authorized an additional share repurchase program for up to $10 billion of the Company’s outstanding common stock. Repurchases will be made in accordance with applicable securities laws from time to time in the open market, through privately negotiated transactions, or otherwise.
On January 27, 2026, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock. The dividend will be paid on March 31, 2026 to stockholders of record at the close of business on March 17, 2026. Item 9.01. Financial Statements and Exhibits. (d) Exhibits:
Exhibit 99.1
Press Release, dated January 27, 2026
Exhibit 104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HCA HEALTHCARE, INC.
Date:
January 27, 2026
By:
/s/ Michael A. Marks
Michael A. Marks Executive Vice President and Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Oct 24, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 24, 2025
0001193125-25-249345
8-K
false000086073000008607302025-10-242025-10-24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 24, 2025
HCA Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter)
Delaware
001-11239
27-3865930
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
One Park Plaza
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: (615) 344-9551
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
HCA
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition. On October 24, 2025, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2025, the text of which is set forth as Exhibit 99.1. Item 7.01. Regulation FD Disclosure. On October 24, 2025, the Company issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2025, the text of which is set forth as Exhibit 99.1. Item 8.01. Other Events. On October 24, 2025, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.72 per share of the Company’s common stock. The dividend will be paid on December 29, 2025 to stockholders of record at the close of business on December 15, 2025. Item 9.01. Financial Statements and Exhibits. (d) Exhibits:
Exhibit 99.1
Press Release, dated October 24, 2025
Exhibit 104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HCA HEALTHCARE, INC.
Date:
October 24, 2025
By:
/s/ Michael A. Marks
Michael A. Marks Executive Vice President and Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Jul 25, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 25, 2025
0000950170-25-098578
8-K
0000860730false00008607302025-07-252025-07-25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 25, 2025
HCA Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter)
Delaware
001-11239
27-3865930
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
One Park Plaza
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: (615) 344-9551
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
HCA
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition. On July 25, 2025, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its results of operations for the second quarter ended June 30, 2025, the text of which is set forth as Exhibit 99.1. Item 7.01. Regulation FD Disclosure. On July 25, 2025, the Company issued a press release announcing, among other matters, its results of operations for the second quarter ended June 30, 2025, the text of which is set forth as Exhibit 99.1. Item 8.01. Other Events. On July 25, 2025, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.72 per share of the Company’s common stock. The dividend will be paid on September 30, 2025 to stockholders of record at the close of business on September 16, 2025. Item 9.01. Financial Statements and Exhibits. (d) Exhibits:
Exhibit 99.1
Press Release, dated July 25, 2025
Exhibit 104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HCA HEALTHCARE, INC.
Date:
July 25, 2025
By:
/s/ Michael A. Marks
Michael A. Marks Executive Vice President and Chief Financial Officer
Latest HCA Healthcare Inc. News
HCA Breaking Stock News: Dive into HCA Ticker-Specific Updates for Smart Investing
Business Wire
HCA Healthcare Named as One of the 2026 World’s Most Ethical Companies by Ethisphere
📈
AI Sentiment
Highly Positive
8/10
Motley Fool
2 Stocks That Could Create Lasting Generational Wealth
📈
AI Sentiment
Highly Positive
8/10
Compare HCA vs Leading Stocks
See how HCA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HCA HCA Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.